Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 21, 2020; 26(31): 4680-4693
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4680
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4680
Variable | B | Wald | P value | HR | 95%CI |
PFS | |||||
Adjuvant chemotherapy (Performed vs none) | 1.861 | 15.075 | < 0.001 | 6.432 | 2.514-16.485 |
OS | |||||
N stage (Absent vs present) | -0.853 | 5.079 | 0.024 | 0.426 | 0.203-0.895 |
Adjuvant chemotherapy (Performed vs none) | 1.351 | 7.658 | 0.006 | 3.862 | 1.483-10.058 |
Degree of enhancement (Mild vs moderate/marked) | 0.774/-0.212 | 6.581 | 0.037 | 2.169/0.809 | 0.827-5.689/0.285-2.296 |
- Citation: Zhou Y, Hou P, Zha KJ, Wang F, Zhou K, He W, Gao JB. Prognostic value of pretreatment contrast-enhanced computed tomography in esophageal neuroendocrine carcinoma: A multi-center follow-up study. World J Gastroenterol 2020; 26(31): 4680-4693
- URL: https://www.wjgnet.com/1007-9327/full/v26/i31/4680.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i31.4680